[Platelet activation marker]

Shosaku Nomura1

  • 1First Department of Internal Medicine, Kansai Medical University, Moriguchi 570-8507.

Rinsho Byori. the Japanese Journal of Clinical Pathology
|December 19, 2003
PubMed

Insights

Diabetic patients show elevated platelet activation markers and platelet-derived microparticles (PDMP), contributing to atherosclerosis. These markers may help assess vascular damage in diabetes.

Area of Science:

  • Cardiovascular Medicine
  • Diabetology
  • Hematology

Context:

  • Atherosclerosis is a major cause of mortality in diabetes mellitus.
  • Traditional risk factors do not fully explain the increased atherosclerosis incidence in diabetic patients.
  • Diabetic platelets exhibit heightened aggregation sensitivity and elevated activation markers.

Purpose:

  • To investigate the role of platelet activation markers and platelet-derived microparticles (PDMP) in diabetes-associated atherosclerosis.
  • To explore the relationship between platelet activation, shear stress, and PDMP generation in diseased vasculature.
  • To assess the utility of platelet activation markers in evaluating vascular damage in diabetic individuals.

Summary:

  • Elevated platelet activation markers (CD62P, CD63, PAC-1, Annexin V) and PDMP are observed in diabetes.
  • PDMP, expressing procoagulant phospholipids, are implicated in disease pathogenesis.
  • High shear stress induces platelet aggregation and PDMP shedding, relevant to microvascular conditions.
  • Platelet activation markers and PDMP may contribute to atherosclerosis development in diabetes.

Impact:

  • Platelet activation markers may serve as valuable indicators for assessing vascular damage in diabetic patients.
  • Understanding PDMP's role can inform strategies for managing atherosclerosis in diabetes.
  • This research highlights the complex interplay between platelet function and cardiovascular complications in diabetes.

Related Concept Videos

Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...